Ginell R Post

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Fluorescence Imaging

Pulmonary Embolism

Vascular Endothelial Growth Factor

Machine Learning

Top Venues

Clinical case reports

Journal of clinical pathology

Molecular cancer therapeutics

University of Arkansas for Medical Sciences

University of Chicago (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Arkansas for Medical Sciences Aug 08 2008

United States

Associate Professor :: Pathology

Education History

University of Chicago Jun 01 1984 - Jun 30 1992

United States

PHD :: Biochemistry and Molecular Biology

Publications

Mason McCrury, Kennith Swafford, Sydnye L Shuttleworth, Syed Hassan Mehdi, Baku Acharya, Debasmita Saha, Kevin Naceanceno, Stephanie D Byrum, Aaron J Storey, Ying-Zhi Xu, Claire Doshier, Vijay Patel, Ginell R Post, Annick De Loose, Analiz Rodriguez, Leonard D Shultz, Fenghuang Zhan, Donghoon Yoon, Brendan Frett, Samantha Kendrick
Bifunctional inhibitor reveals NEK2 as a therapeutic target and regulator of oncogenic pathways in lymphoma. Molecular cancer therapeutics (2023)
Azin Mashayekhi, Eleonora Fiorletta Quiroga, Joseph F Margolick, Ginell R Post
Intestinal T-cell lymphoma: A rare entity presenting with severe acute upper quadrant pain. Clinical case reports 10 (3) (2022)
Glenn P Murray, Steven R Post, Ginell R Post
ABO blood group is a determinant of von Willebrand factor protein levels in human pulmonary endothelial cells. Journal of clinical pathology 73 (6) (2019)
Jonathon Gralewski, Ginell R Post
Cutaneous intralymphatic CD30+ pseudolymphoma: a reactive condition mimicking lymphoma. Blood 132 (17) (2019)